eChapters

Introduction
Antimicrobial resistance (AMR) is one of the top global public health threats. It is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths (Murray et al., 2019).Despite its magnitude, public awareness of AMR remains low. Unlike tobacco smoke, antibiotics are potentially life-saving medications, but it is just as vital to understand the risks of overuse and their impact on future effectiveness in society as a whole (Langfordet al., 2019). Effective risk communication is essential to addressing AMR because it not only informs professional and community stakeholders but also nurturesbehaviour change across sectors. Within a One Health framework, risk communication connects human medicine, veterinary practice, agriculture, and environmental management, ensuring coordinated responses to reduce misuse and overuse of antimicrobials. This article explores the role of risk communication in combating AMR, highlighting global lessons, challenges, and strategies to strengthen communication systems for sustainable containment.
The Growing Threat of AMR
AMR occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve mechanisms to resist drugs that once effectively treated them. Misuse and overuse of antimicrobials in human health, livestock, aquaculture, and crop production accelerate resistance. According to WHO, AMR is projected to cause 10 million deaths annually by 2050 if left unaddressed (O’Neill, 2016). In countries like India, with high infectious disease burdens and large-scale antimicrobial consumption, the risks are particularly acute. Communicating these risks clearly and effectively is critical for influencing prescribing practices, agricultural use, and community awareness.Persistent misconceptions include beliefs that antibiotics are effective against viral illnesses and the mistaken notion that it is the human body, rather than bacteria, that develops resistance (Muflihet al., 2021). These knowledge gaps are often linked to insufficient or ineffective health communication (Krockowet al., 2023), sparse media coverage compared to threats like sepsis (Fitzpatrick et al., 2019).
Challenges in AMR Risk Communication
1. Low Public Awareness: Despite the global severity ofAMR, public awareness remains critically low. Surveys have found that a mere fraction of the population grasp its implications, with some reporting only ~8–11% demonstrating adequate understanding and many feeling powerless to contribute (Goshaet al., 2024).
2. Ineffective understanding of Terminology: It is recognized that AMR has a ‘language problem’ and the way in which healthcare professionals communicate about AMR may not always resonate with patients (Langford et al., 2019). Technical labels like “AMR” or “antimicrobial resistance” fall short in public communication. Experiments reveal that phrases such as “Antibiotic Resistance” or “Antibiotic Crisis” are more memorable and better at promoting critical behaviors—like completing prescribed antibiotic courses—than more formal terminology.
3. Misconceptions about Antibiotics: Widespread misunderstandings persist regarding antibiotics’ purpose and effect. Many incorrectly believe antibiotics treat viruses—common colds, flu, or even are effective painkillers (Gunasekara et al., 2022).Some think AMR occurs because the body becomes resistant, rather than bacteria evolving resistance(Muflihet al., 2021).
4. Complexity of the Issue: AMR is inherently multifaceted—spanning interactions among humans, animals, and the environment—which makes it challenging to distill into clear, actionable messages. Understanding Risk

Introduction
Antimicrobial resistance (AMR) has emerged as one of the most alarming public health challenges of the 21st century, threatening the effectiveness of life-saving drugs and the future of modern medicine. This crisis is not limited to healthcare settings; it spans communities, agriculture, and the environment, impacting every facet of society. India, with its large population, high burden of infectious diseases, unregulated access to antibiotics, and considerable pharmaceutical manufacturing industry, stands at the forefront of the global struggle against AMR. The rise of resistant microbes stems from a complex interplay of factors: overuse and misuse of antibiotics in humans and animals, poor infection prevention practices, lack of sanitation, and environmental contamination from antibiotic waste. As a result, common infections are becoming harder to treat, surgical procedures riskier, and healthcare costs are escalating, all leading to increased morbidity and mortality. Tackling AMR requires robust intersectoral collaboration—no single stakeholder can succeed alone. Non-governmental organizations (NGOs), industries, and Corporate Social Responsibility (CSR) initiatives form a critical triad in India’s fight against AMR. NGOs drive grassroots education, advocacy, surveillance, and policy change, often bridging gaps where governmental capacity is limited. The pharmaceutical and healthcare industries, responsible for antibiotic manufacturing, distribution, stewardship, and infection control, play a pivotal role in curbing environmental emissions, supporting responsible use, and promoting the discovery of new treatments. Meanwhile, CSR channels the resources and expertise of corporations towards sustainable, communityfacing projects that promote awareness, improve hygiene, foster stewardship, and drive systemic change.

Introduction
Animal sector is growing very fast particularly in India as people’s purchasing power is increasing day by day. With increase in income, people’s dietary habit is shifting towards more animal origin products. The use of antibiotics for animal food production is growing very fast and India is the 4th largest country in the world regarding consumption of antibiotics in veterinary and animal husbandry sector. There is urgent need of AMR mitigation strategies to reduce the effect on human and animal health. As per the World Bank AMR can affect the global GDP upto 3.8% by 2050. Most of the countries in the world are very cautious regarding antibiotic residues and rejecting the livestock products which lead to economic loss. Many world agencies/forum such as CodexAMR Guidelines, UN Political Declaration on AMR Guidelines, Global Leaders Group on AMR reiterated judicious use of antibiotics. All-India Network Project on AMR inLivestock and Fisherieswas started in India to reduce the effect of AMR by educational awareness, adoption at field level, surveillance system and diagnosis but it didn’t meet out the desired outcome. Capacity building programmes in the field of AMR by training, reform in curriculum, collaboration from different fields of professionals can mitigate the harmful effect of AMR. According to the Food and Agriculture Organization (FAO), education and training play pivotal roles in translating knowledge into practical implementation, warranting the inclusion of Antimicrobial Use and AMR as integral components in professional education, postgraduate training, and continuing education within the food and agricultural sectors Training Strategies It involve Antimicrobial Stewardship training for healthcare professionals, public awareness campaigns, farmer education, and veterinary training on responsible antimicrobial use. Other critical elements include fostering collaboration through professional networks, building surveillance capacity, utilizing AI-driven tools for better decision-making, and promoting hygiene and infection prevention to reduce infection incidence and the need for antibiotics.
Training for Healthcare Professionals
There is substantial evidence that both healthcare workers and members of the public have knowledge gaps about appropriate use of antibiotics and mechanisms of antibiotic resistance. Surveillance is a prerequisite to estimate the magnitude of the AMR burden and to establish any intervention strategies, such as antimicrobial stewardship. In order to launch successful intervention approaches through cooperative efforts from different stakeholders (e.g., international agencies, human and veterinary medicine sectors, agriculture and animal production industries, and consumers), the existing knowledge gap needs to be addressed first.

Introduction
Antimicrobial resistance (AMR) has emerged as one of the most pressing global health threats, with implications that extend beyond human medicine to animal health, food security, and the environment. In livestock production systems, the misuse and overuse of antibiotics contribute significantly to the development of resistant pathogens. These resistant organisms can spread from animals to humans through direct contact, contaminated food products, and environmental pathways. The containment of AMR in livestock is not solely a technical or regulatory challenge—it is also a social and behavioral issue. Public awareness, education, and behavioural change are key pillars of any effective AMR mitigation strategy. Schools, community networks, and media platforms play vital roles in shaping knowledge, attitudes, and practices related to antibiotic use in livestock.
Causes of AMR in Livestock
Over-prescription and misuse of antibiotics in veterinary care Use of antimicrobials as growth promoters rather than for therapeutic purposes Poor farm bio-security and hygiene leading to frequent infections
Inadequate regulation and over-the-counter sale of antibiotics without veterinary oversight
Public Health Impact
Transmission of resistant pathogens via the food chain Contamination of soil and water with resistant genes through manure
Emergence of zoonotic diseases with limited treatment options

Introduction
AMR is a critical global problem that affects human, environmental, and animal health. AMR is a complex problem; it is necessary to look at it from different disciplines to frame it within the One Health approach [Shrestha,2018].The World Health Organization (WHO) has identified AMR as a top ten global public health threat.Globally, there were an estimated 4.95 million deaths associated with bacterial AMR in 2019, including 1.27 million deaths attributable to bacterial AMR [O’Neill, J. (2016)]. The economic impact is equally alarming. The World Bank projects that AMR could lead to an additional US$ 1 trillion in healthcare costs by 2050, and over US$ 1 trillion in annual gross domestic product (GDP) losses by 2030.The One Health approach is defined as a joint effort of various disciplines that come together to provide solutions for human, animal, and environmental health. AMR is linked to each of these three components due to the irresponsible and excessive use of antimicrobials in various sectors (agriculture, cattle raising, and human medicine). Under the pressure of antimicrobial selection, bacteria acquire resistance genes and mobile genetic elements that can spread to other bacteria of the same or different genus. When bacteria acquire resistance to antimicrobials, they also acquire a greater ability to proliferate in animals, humans, and the natural world. Mismanagement of antimicrobials, inadequate infection control, agricultural debris, contaminants in the environment, and migration of people and animals infected with resistant bacteria facilitate the spread of resistance [Collignon,et.,al,2018]. AMR represents a global public health problem, for which epidemiological surveillance systems have been established, aiming to promote collaborations directed at the well-being of human and ani mal health and the balance of the ecosystem. Several international organizations (The World Organisation for Animal Health [OIE], WHO, and the Food and Agriculture Organization of the United Nations [FAO]) have joined forces to develop a Global Action Plan on Antimicrobial Resistance-WHO. Action taken in this plan included understanding the AMR from surveillance and research. The advisory group established guidelines for AMR surveillance to ensure all countries implement integrated surveillance, which will cover the use and consumption of antimicrobials in the human and animal population. These guide lines will provide a clear understanding of how AMR spreads in different settings and specific areas. It will allow to study the correlation between AMR and antimicrobial use in a different setting (animals, humans, and environment) and to assess the effect of interventions within and between sectors [W.H.O 2015,2017].